Cargando…
Chronic psychosis associated with new hallucinogenic drug 25I-NBOMe
INTRODUCTION: The presence of perceptual disturbances and psychotic symptoms associated with substance abuse are widely known. While the abuse of substances is becoming more widespread, there is a general perception that their use entails fewer risks. 25I-NBOMe is a recently introduced hallucinogeni...
Autores principales: | Martin-Santiago, O., Guerra-Valera, G., Alario-Ruiz, C., Navarro-Barriga, N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661179/ http://dx.doi.org/10.1192/j.eurpsy.2023.1319 |
Ejemplares similares
-
Neurotoxicological profile of the hallucinogenic compound 25I-NBOMe
por: Herian, Monika, et al.
Publicado: (2022) -
Tolerance to neurochemical and behavioral effects of the hallucinogen 25I-NBOMe
por: Herian, Monika, et al.
Publicado: (2021) -
Neurochemical and Behavioral Effects of a New Hallucinogenic Compound 25B-NBOMe in Rats
por: Wojtas, Adam, et al.
Publicado: (2020) -
Neurotoxic effects of hallucinogenic drugs 25H-NBOMe and 25H-NBOH in organotypic hippocampal cultures
por: Cassiano, Larissa Marcely Gomes, et al.
Publicado: (2023) -
Contribution of serotonin receptor subtypes to hallucinogenic activity of 25I-NBOMe and to its effect on neurotransmission
por: Herian, Monika, et al.
Publicado: (2020)